| Name | 4-[(1S)-1-Cyclopropyl-2-methoxyethyl]-6-{[6-(difluoromethoxy)-2,5 -dimethyl-3-pyridinyl]amino}-5-oxo-4,5-dihydro-2-pyrazinecarbonit rile |
|---|---|
| Synonyms |
BMS-764459 >= (HPLC)
BMS 764459,BMS 2-Pyrazinecbonitrile, 4-[(1S)-1-cyclopropyl-2-Methoxyethyl]-6-[[6-(difluoroMethoxy)-2,5-diMethyl-3-pyridinyl]amino]-4,5-dihydro-5-oxo 4-[(1S)-1-cyclopropyl-2-methoxyethyl]-6-[[6-(difluoromethoxy)-2,5-dimethylpyridin-3-yl]amino]-5-oxopyrazine-2-carbonitrile |
| Description | BMS-764459 is a CRF1 antagonist. BMS-764459 can be used for the research of neurological disorders such as depression and anxiety. BMS-764459 is also an atypical CYP1A1 inducer[1][2]. |
|---|---|
| Related Catalog | |
| Target |
CRF1[1], CYP1A1[2] |
| References |
| Molecular Formula | C19H21F2N5O3 |
|---|---|
| Molecular Weight | 405.39900 |
| Exact Mass | 405.16100 |
| PSA | 105.29000 |
| LogP | 2.49118 |